EXCEED THE SPACE PROVIDED. The Division of Allergy and Infectious Diseases at the University of Washington has trained 79 physician-scientists through continuous funding provided by this training grant since its inception in 1976. Approximately80% of these trainees remain in academic and research positions. The continuing objective of the program is to providepost-doctoral training for physician-scientists committed to an academic career in infectious diseases, with particular emphasis on research training. The pool of applicants consists of MDs who are completing their training in internal medicine. Approximately 70 applications for positions are received annually, and approximately half of the applicants are interviewed. Eighty percent of those offered positions accept. The current proposal requests funding for 8 trainees per year. The program generally requires three years of tra ning, two of which are supported by this training grant. All trainees complete a core curriculum consisting of required didactic, research and clinical activities. Subsequently,each trainee selects a mentor for detailed research training in one of 6 research tracks, including pathogenesis of viral diseases; pathogenesis of bacterial and parasitic diseases; infectious disease immunology and inflammation; immunocompromised host; clinical epidemiology of infectious diseases; and clinical trials. Specific curricula for trainees in each track include didactic exercises, conferences, lectures, seminars, journal clubs, and formal universitycourses. Fellows interestedin epidemiology may also obtain an MPH degree. The training faculty consists of 44 full timefaculty members in the Departments of Medicine, Laboratory Medicine, Microbiology, Pediatrics, Immunology and Epidemiology. Interdisciplinary training is encouraged and many trainees are jointly supervised by faculty in both a basic science and a clinical department. In addition, many of the training faculty collaborate extensively in both research and training activities. The trainee facilities include the laboratories of these faculty at the University of Washington affiliatedhospitals (Harborview Medical Center, University of Washington Medical Center, and the Veterans Affairs Puget Sound Health Care System, Seattle Division) as well as the Fred Hutchinson Cancer Research Center, the UW Clinical Research Center, the Regional Primate Center, and the Seattle King County Department of Public Health. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007044-30
Application #
6908078
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Mcsweegan, Edward
Project Start
1976-07-01
Project End
2006-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
30
Fiscal Year
2005
Total Cost
$372,031
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Simmons, Jason D; Stein, Catherine M; Seshadri, Chetan et al. (2018) Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol 18:575-589
Goldberg, Drew W; Tenforde, Mark W; Mitchell, Hannah K et al. (2018) Neurological Sequelae of Adult Meningitis in Africa: A Systematic Literature Review. Open Forum Infect Dis 5:ofx246
Hahn, William O; Butler, Noah S; Lindner, Scott E et al. (2018) cGAS-mediated control of blood-stage malaria promotes Plasmodium-specific germinal center responses. JCI Insight 3:
Tenforde, M W; Longley, N; Meya, D B et al. (2018) Poor specificity of urinary cryptococcal antigen testing: Reply to Drain et al. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal. HIV Med 19:e47-e48
Ford, Emily S; Horne, David J; Shah, Javeed A et al. (2017) Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State. Ann Am Thorac Soc 14:1129-1138
Scriven, James E; Tenforde, Mark W; Levitz, Stuart M et al. (2017) Modulating host immune responses to fight invasive fungal infections. Curr Opin Microbiol 40:95-103
Shah, Javeed A; Musvosvi, Munyaradzi; Shey, Muki et al. (2017) A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin-Specific Immune Responses and Tuberculosis. Am J Respir Crit Care Med 196:502-511
Mikacenic, Carmen; Price, Brenda L; Harju-Baker, Susanna et al. (2017) A Two-Biomarker Model Predicts Mortality in the Critically Ill with Sepsis. Am J Respir Crit Care Med 196:1004-1011
Bajema, Kristina L; Dalesandro, Mark F; Fredricks, David N et al. (2017) Disseminated coccidioidomycosis presenting with intramedullary spinal cord abscesses: Management challenges. Med Mycol Case Rep 15:1-4
Bajema, Kristina L; Pakzad-Vaezi, Kaivon; Hawn, Thomas et al. (2017) Tuberculous uveitis: association between anti-tuberculous therapy and clinical response in a non-endemic country. J Ophthalmic Inflamm Infect 7:19

Showing the most recent 10 out of 100 publications